Pharmacology of the AC AT Inhibitor Avasimibe (CI‐1011)
- 1 March 2003
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 21 (1), 33-50
- https://doi.org/10.1111/j.1527-3466.2003.tb00104.x
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- The combined effect of inhibiting both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regressionAtherosclerosis, 2001
- Different effect of simvastatin and atorvastatin on key enzymes involved in VLDL synthesis and catabolism in high fat/cholesterol fed rabbitsBritish Journal of Pharmacology, 1999
- Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wallBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Effect of membrane environment on inhibition of acyl-CoA:Cholesterol acyltransferase by a range of synthetic inhibitorsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Hepatic and Adrenal Toxicity of a Novel Lipid Regulator in Beagle DogsFundamental and Applied Toxicology, 1995
- Differential effects of an acyl‐coenzyme A: cholesterol acyltransferase inhibitor on HDL‐induced cholesterol efflux from rat macrophage foam cellsFEBS Letters, 1995
- Bile acid synthesis in hamster hepatocytes in primary culture: Sources of cholesterol and comparison with other speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Lipoprotein Lp(a). A risk factor for myocardial infarction.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- The role of acyl-CoA:cholesterol acyltransferase in the metabolism of free cholesterol to cholesteryl esters or bile acids in primary cultures of rat hepatocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986